283 related articles for article (PubMed ID: 34213405)
1. The combined vaccination protocol of DNA/MVA expressing Zika virus structural proteins as efficient inducer of T and B cell immune responses.
Pérez P; Martín-Acebes MA; Poderoso T; Lázaro-Frías A; Saiz JC; Sorzano CÓS; Esteban M; García-Arriaza J
Emerg Microbes Infect; 2021 Dec; 10(1):1441-1456. PubMed ID: 34213405
[TBL] [Abstract][Full Text] [Related]
2. Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV.
Marín MQ; Pérez P; Ljungberg K; Sorzano CÓS; Gómez CE; Liljeström P; Esteban M; García-Arriaza J
J Virol; 2019 Apr; 93(7):. PubMed ID: 30674625
[TBL] [Abstract][Full Text] [Related]
3. A Vaccine Based on a Modified Vaccinia Virus Ankara Vector Expressing Zika Virus Structural Proteins Controls Zika Virus Replication in Mice.
Pérez P; Q Marín M; Lázaro-Frías A; Jiménez de Oya N; Blázquez AB; Escribano-Romero E; S Sorzano CÓ; Ortego J; Saiz JC; Esteban M; Martín-Acebes MA; García-Arriaza J
Sci Rep; 2018 Nov; 8(1):17385. PubMed ID: 30478418
[TBL] [Abstract][Full Text] [Related]
4. Humoral and cellular immunity against both ZIKV and poxvirus is elicited by a two-dose regimen using DNA and non-replicating vaccinia virus-based vaccine candidates.
Zhan Y; Deng Y; Huang B; Song Q; Wang W; Yang Y; Dai L; Wang W; Yan J; Gao GF; Tan W
Vaccine; 2019 Apr; 37(15):2122-2130. PubMed ID: 30851967
[TBL] [Abstract][Full Text] [Related]
5. Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization.
Lin HH; Yang SP; Tsai MJ; Lin GC; Wu HC; Wu SC
Theranostics; 2019; 9(16):4811-4826. PubMed ID: 31367259
[TBL] [Abstract][Full Text] [Related]
6. Vaccine protection against Zika virus from Brazil.
Larocca RA; Abbink P; Peron JP; Zanotto PM; Iampietro MJ; Badamchi-Zadeh A; Boyd M; Ng'ang'a D; Kirilova M; Nityanandam R; Mercado NB; Li Z; Moseley ET; Bricault CA; Borducchi EN; Giglio PB; Jetton D; Neubauer G; Nkolola JP; Maxfield LF; De La Barrera RA; Jarman RG; Eckels KH; Michael NL; Thomas SJ; Barouch DH
Nature; 2016 Aug; 536(7617):474-8. PubMed ID: 27355570
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a Species E Adenovirus Vector as a Zika virus vaccine.
Bullard BL; Corder BN; Gordon DN; Pierson TC; Weaver EA
Sci Rep; 2020 Feb; 10(1):3613. PubMed ID: 32107394
[TBL] [Abstract][Full Text] [Related]
8. Maternal immunization with a DNA vaccine candidate elicits specific passive protection against post-natal Zika virus infection in immunocompetent BALB/c mice.
Wang R; Liao X; Fan D; Wang L; Song J; Feng K; Li M; Wang P; Chen H; An J
Vaccine; 2018 Jun; 36(24):3522-3532. PubMed ID: 29753607
[TBL] [Abstract][Full Text] [Related]
9. A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein.
Li A; Yu J; Lu M; Ma Y; Attia Z; Shan C; Xue M; Liang X; Craig K; Makadiya N; He JJ; Jennings R; Shi PY; Peeples ME; Liu SL; Boyaka PN; Li J
Nat Commun; 2018 Aug; 9(1):3067. PubMed ID: 30076287
[TBL] [Abstract][Full Text] [Related]
10. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus.
Garg H; Sedano M; Plata G; Punke EB; Joshi A
J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019
[TBL] [Abstract][Full Text] [Related]
11. An inactivated recombinant rabies virus displaying the Zika virus prM-E induces protective immunity against both pathogens.
Jin H; Jiao C; Cao Z; Huang P; Chi H; Bai Y; Liu D; Wang J; Feng N; Li N; Zhao Y; Wang T; Gao Y; Yang S; Xia X; Wang H
PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009484. PubMed ID: 34086672
[TBL] [Abstract][Full Text] [Related]
12. A Measles Virus-Based Vaccine Candidate Mediates Protection against Zika Virus in an Allogeneic Mouse Pregnancy Model.
Nürnberger C; Bodmer BS; Fiedler AH; Gabriel G; Mühlebach MD
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429338
[TBL] [Abstract][Full Text] [Related]
13. A single-dose plasmid-launched live-attenuated Zika vaccine induces protective immunity.
Zou J; Xie X; Luo H; Shan C; Muruato AE; Weaver SC; Wang T; Shi PY
EBioMedicine; 2018 Oct; 36():92-102. PubMed ID: 30201444
[TBL] [Abstract][Full Text] [Related]
14. Immunization With a Novel Human Type 5 Adenovirus-Vectored Vaccine Expressing the Premembrane and Envelope Proteins of Zika Virus Provides Consistent and Sterilizing Protection in Multiple Immunocompetent and Immunocompromised Animal Models.
Guo Q; Chan JF; Poon VK; Wu S; Chan CC; Hou L; Yip CC; Ren C; Cai JP; Zhao M; Zhang AJ; Song X; Chan KH; Wang B; Kok KH; Wen Y; Yuen KY; Chen W
J Infect Dis; 2018 Jul; 218(3):365-377. PubMed ID: 29617816
[TBL] [Abstract][Full Text] [Related]
15. Preventative Vaccines for Zika Virus Outbreak: Preliminary Evaluation.
Kim E; Erdos G; Huang S; Kenniston T; Falo LD; Gambotto A
EBioMedicine; 2016 Nov; 13():315-320. PubMed ID: 27717627
[TBL] [Abstract][Full Text] [Related]
16. Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies.
Garber DA; O'Mara LA; Zhao J; Gangadhara S; An I; Feinberg MB
PLoS One; 2009; 4(5):e5445. PubMed ID: 19421328
[TBL] [Abstract][Full Text] [Related]
17. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
[TBL] [Abstract][Full Text] [Related]
18. Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage.
Xu K; Song Y; Dai L; Zhang Y; Lu X; Xie Y; Zhang H; Cheng T; Wang Q; Huang Q; Bi Y; Liu WJ; Liu W; Li X; Qin C; Shi Y; Yan J; Zhou D; Gao GF
J Virol; 2018 Mar; 92(6):. PubMed ID: 29298885
[TBL] [Abstract][Full Text] [Related]
19. Vesicular Stomatitis Virus and DNA Vaccines Expressing Zika Virus Nonstructural Protein 1 Induce Substantial but Not Sterilizing Protection against Zika Virus Infection.
Li A; Xue M; Attia Z; Yu J; Lu M; Shan C; Liang X; Gao TZ; Shi PY; Peeples ME; Boyaka PN; Liu SL; Li J
J Virol; 2020 Aug; 94(17):. PubMed ID: 32554698
[TBL] [Abstract][Full Text] [Related]
20. A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection.
García-Arriaza J; Cepeda V; Hallengärd D; Sorzano CÓ; Kümmerer BM; Liljeström P; Esteban M
J Virol; 2014 Mar; 88(6):3527-47. PubMed ID: 24403588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
